Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Quick-Med Technologies, a life sciences company, has announced that the US Patent and Trademark Office has issued new patent to the company covering select uses of the Nimbus technology.
Subscribe to our email newsletter
This patent stems from a provisional patent application filed with the US Patent and Trademark Office in February 2004 by Quick-Med.
The new patent, together with a previously issued patent and eleven additional pending patent applications plus foreign counterparts pending in Europe, Australia, Brazil, Canada, China, India, Japan, Mexico, and South Africa, provide broad coverage for Nimbus, a next-generation antimicrobial technology.
Quick-Med has already licensed its first product, Nimbus gauze, to Derma Sciences, a provider of advanced wound care products. Derma Sciences will market the product after Quick-Med receives FDA clearance.